| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 07/13/2005 | CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639118A Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
| 07/13/2005 | CN1637018A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636978A Pyrrolidinyl metalloprotease inhibitor and its application |
| 07/13/2005 | CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 07/13/2005 | CN1636976A Mutilin derivatives and their use as antibacterials |
| 07/13/2005 | CN1636967A Noval compounds, their use and preparation |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636593A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636457A Fungicides for the control of take-all disease of plants |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/12/2005 | US6916856 Thermosetting resin compositions containing maleimide and/or vinyl compounds |
| 07/12/2005 | US6916850 Pyruvate derivatives |
| 07/12/2005 | US6916842 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with cyano compounds |
| 07/12/2005 | US6916829 Method for enhancing mutant enzyme activity in gaucher disease |
| 07/12/2005 | US6916346 Primary intermediates for oxidative coloration of hair |
| 07/07/2005 | WO2005061464A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/07/2005 | WO2005061454A1 Agent or method for treatment for severe aphasia in chronic-stage cerebrovascular disorder |
| 07/07/2005 | WO2005061453A1 Antharquinone compounds as anti cancer compounds |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005037810A3 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof |
| 07/07/2005 | WO2005032471A3 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/07/2005 | US20050148780 Hydrolysis to produce 3-(5,5-Dimethyl-1,3-dioxan-2-yl)-1-(4-ethoxyphenyl)butan-1-one, as intermediates for producing a 4-methyl-1,2-diarylpyrrole derivative; simple and safe procedure in a high yield and purity product, not using nitromethane |
| 07/07/2005 | US20050148773 labeling reagents; powerful tools for analyte analysis, including but not limited to multiplex proteomic analysis; comprises one or more heavy atom isotopes; intermediates in the synthesis of active esters of N-substituted piperazine acetic acid |
| 07/07/2005 | US20050148771 Active esters of N-substituted piperazine acetic acids, including isotopically enriched versions thereof |
| 07/07/2005 | US20050148655 Production of N-(methyl aryl)-2-lactam, N-(methyl cycloalkyl)-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl cyano compounds |
| 07/07/2005 | US20050148653 Polymaleimide compounds and their medical use |
| 07/07/2005 | US20050148637 Neurotrophic low molecular weight ketones and tioester compounds for treatment of nervous system disorders and neurodegenerative conditions |
| 07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/07/2005 | US20050148599 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 07/07/2005 | US20050148564 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/07/2005 | US20050148549 Compositions and methods for inhibition of phospholipase a2 mediated inflammation |
| 07/07/2005 | US20050148517 Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
| 07/07/2005 | US20050144741 Composition for dyeing keratin fibres with a cationic direct dye and a thickening polymer |
| 07/07/2005 | CA2550839A1 Antharquinone compounds as anti cancer compounds |
| 07/07/2005 | CA2548354A1 Herbicidal heteroaroyl-substituted phenylalanine amides |
| 07/06/2005 | EP1550651A1 Glycerol derivative |
| 07/06/2005 | EP1549685A1 Novel nitrosation polymer in organic synthesis |
| 07/06/2005 | EP1549283A1 Merocyanine derivatives for cosmetic use |
| 07/06/2005 | EP0776327B1 New multimerizing agents |
| 07/06/2005 | CN1634884A Process for recovery of N-methylpyrrolidone from lithium cell discharge gas |
| 07/06/2005 | CN1634883A Process for preparing 2-substituted enamine or enoyl amine |
| 07/06/2005 | CN1634864A 9, 9-bis(triphenyl amino) fluorine derivatives and preparation and use thereof |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/05/2005 | US6913674 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 06/30/2005 | WO2005059037A1 Reagent for detecting an analyte |
| 06/30/2005 | WO2005058986A1 Polyamine salts as clay stabilizing agents |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058865A2 Assay for entactogens |
| 06/30/2005 | WO2005058857A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/30/2005 | WO2005058849A1 New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them |
| 06/30/2005 | WO2005058845A2 Novel glucagon antagonists/inverse agonists |
| 06/30/2005 | WO2005058839A1 Optically active carboxamides and use thereof to combat undesirable microorganisms |
| 06/30/2005 | WO2005058832A1 Diacylhydrazine derivatives |
| 06/30/2005 | WO2005058818A1 Process for the recovery of nitroxy compounds from organic solutions and oxidation process |
| 06/30/2005 | WO2005058817A1 Prolinylarylacetamides |
| 06/30/2005 | WO2005058816A1 Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours |
| 06/30/2005 | WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005037227A3 Selective cox-2 inhibitors |
| 06/30/2005 | WO2005034878A3 Pyrovalerone analogs and therapeutic uses thereof |
| 06/30/2005 | WO2005020899A3 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 06/30/2005 | WO2005016242A8 Synthetic process for trans-aminocyclohexyl ether compounds |
| 06/30/2005 | WO2004075847A3 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS |
| 06/30/2005 | US20050143585 Processes for preparing pyrroles |
| 06/30/2005 | US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 06/30/2005 | US20050143475 Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 06/30/2005 | US20050143445 anticonvulsant drug; crystallization in acetone solvent or from dissolving in water, or dimethyl sulfoxide |
| 06/30/2005 | US20050143443 4-substituted pyrrole-2-carboxylic acidsand 5-substituted pyrazole-3-carboxylic acids/esters/salts; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143418 Pesticidal heterocycles |
| 06/30/2005 | US20050143372 Compounds, pharmaceutical compositions and methods of use therefor |
| 06/30/2005 | US20050143368 Chemical compounds |
| 06/30/2005 | US20050143319 Peptide like compounds for treating coronavirus or hepatitis C virus; severe acute respiratory distress syndrome |
| 06/30/2005 | US20050143315 N-[5-[[[5-[[[2-[(aminoiminomethyl)amino]ethyl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]amino]carbonyl]-1-methyl-1H-pyrrol-3-yl]-4-[[[4-[(2-bromo-1-oxo-2-propenyl)amino]-1-methyl-1H-pyrrol-2-yl]carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide hydrochloride having radiosensitisation activity |
| 06/30/2005 | US20050142614 Methods for ligand discovery |
| 06/30/2005 | US20050142489 Squarylium dyes as light-absorbing compound in the information layer of optical data carriers |
| 06/30/2005 | CA2549821A1 Optically active carboxamides and use thereof to combat undesirable microorganisms |
| 06/30/2005 | CA2549741A1 Reagent for detecting an analyte |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549589A1 Prolinylarylacetamides |
| 06/30/2005 | CA2548571A1 Diacylhydrazine derivatives |
| 06/30/2005 | CA2548391A1 Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours |
| 06/30/2005 | CA2546469A1 Polyamine salts as clay stabilizing agents |
| 06/30/2005 | CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/29/2005 | EP1548004A1 Biological low-molecular weight derivatives |
| 06/29/2005 | EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 06/29/2005 | EP1547598A1 NOVEL USES OF PROSTAGLANDIN D sb 2 /sb , PROSTAGLANDIN D sb 2 /sb AGONIST AND PROSTAGLANDIN D sb 2 /sb ANTAGONIST |
| 06/29/2005 | EP1547593A1 Medicinal composition |
| 06/29/2005 | EP1547590A1 Melanin extinguisher |
| 06/29/2005 | EP1546673A2 Novel green and orange fluorescent labels and their uses |
| 06/29/2005 | EP1546103A1 Piperazine and piperidine derivatives for treatment of neurological diseases |